FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA Compliance for Peptide Therapy and BPC 157 Holt Law In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking The peptide problem: Hype is outrunning the evidence Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives